RAREVSSRRK• 28 Days (Normalized)
RARE vs SRRK (Ultragenyx Pharmaceutical Inc. vs Scholar Rock Holding Corporation)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
RARE Performance $14.19
-45.68%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
SRRK Performance $54.65
+4.99%
Scholar Rock Holding Corporation
Normalized Baseline0.00%
Alpha Spread Margin SRRK LEADS
-50.67%
SRRK outperforming by 50.67%
RARESRRK
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
RARE SRRK
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | RARE Price | RARE Gain (%) | SRRK Price | SRRK Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $14.19 | -45.68% | $54.65 | +4.99% | -50.67% |
| Sep 11, 2026 | $14.30 | -45.27% | $55.41 | +6.46% | -51.73% |
| Sep 10, 2026 | $14.40 | -44.89% | $55.67 | +6.95% | -51.84% |
| Sep 09, 2026 | $14.31 | -45.24% | $54.62 | +4.94% | -50.18% |
| Sep 08, 2026 | $14.88 | -43.05% | $57.42 | +10.32% | -53.37% |
| Sep 04, 2026 | $15.30 | -41.45% | $55.33 | +6.30% | -47.75% |
| Sep 03, 2026 | $14.85 | -43.17% | $55.94 | +7.47% | -50.64% |
| Sep 02, 2026 | $26.53 | +1.53% | $56.10 | +7.78% | -6.25% |
| Sep 01, 2026 | $25.81 | -1.22% | $55.89 | +7.38% | -8.60% |
| Aug 31, 2026 | $25.21 | -3.52% | $56.80 | +9.13% | -12.65% |
| Aug 28, 2026 | $25.61 | -1.99% | $57.80 | +11.05% | -13.04% |
| Aug 27, 2026 | $26.26 | +0.50% | $59.26 | +13.85% | -13.35% |
| Aug 26, 2026 | $26.44 | +1.19% | $60.04 | +15.35% | -14.16% |
| Aug 25, 2026 | $26.46 | +1.26% | $58.25 | +11.91% | -10.65% |
| Aug 24, 2026 | $25.72 | -1.57% | $58.20 | +11.82% | -13.39% |
Page 1 of 2